Michaël Fenster
About Michaël Fenster
Michaël Fenster is the Director and CMC Team Leader at Bristol Myers Squibb, with over 15 years of experience in the pharmaceutical industry and a strong background in organic chemistry.
Current Role at Bristol Myers Squibb
Michaël Fenster holds the position of Director - CMC Team Leader at Bristol Myers Squibb. In this capacity, he oversees teams responsible for Chemistry, Manufacturing, and Controls (CMC) in drug development processes. His role involves strategic planning and execution oversight to ensure efficient and effective progression of pharmaceutical projects. Fenster transitioned into this leadership role from his previous title as Senior Principal Scientist within the same company.
Career Progression at Bristol Myers Squibb
Michaël Fenster has been with Bristol Myers Squibb for over 15 years, progressing through several significant roles. Starting as a Research Investigator II from 2006 to 2009, he then served as Senior Research Investigator I from 2010 to 2013, followed by Senior Research Investigator II until 2016. Subsequently, Fenster was promoted to Principal Scientist, a position he held until 2019, before becoming a Senior Principal Scientist for 7 months. His rapid advancement highlights his expertise and leadership within the company.
Past Research Experience
Prior to his roles at Bristol Myers Squibb, Michaël Fenster worked at the Max-Planck-Institut für Kohlenforschung as a Post-Doctoral Research Fellow from 2004 to 2006. During this time, he was involved in high-level scientific research contributing to advancements in organic chemistry. Additionally, Fenster gained experience at Dow Chemical Inc. and the Pulp and Paper Institute of Canada, where he worked as a Research Assistant in 1997 and 1996, respectively. These roles provided him with valuable insights into both academic and industrial research environments.
Educational Background in Chemistry
Michaël Fenster holds a PhD in Organic Chemistry from The University of British Columbia, where he studied from 1998 to 2004. His doctoral research further solidified his expertise in organic chemistry. Additionally, Fenster earned a BSc in Chemistry from McGill University from 1995 to 1998. This strong educational foundation underpins his extensive career in the pharmaceutical industry and his specialized knowledge in chemical research and development.